48 results on '"Balashova, Elena E."'
Search Results
2. Application of Clinical Blood Metabogram to Type 2 Diabetes Mellitus
3. Linking Clinical Blood Metabogram and Gut Microbiota
4. Clinical Blood Metabogram: Application to Overweight and Obese Patients
5. Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
6. Mass Spectrometric Blood Metabogram: Acquisition, Characterization, and Prospects for Application
7. Current State and Future Perspectives on Personalized Metabolomics
8. Prediction of classical clinical chemistry parameters using a direct infusion mass spectrometry
9. Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
10. Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study
11. Metabolome Profiling in Aging Studies
12. Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
13. Comparative Metabolomic Study of Drosophila Species with Different Lifespans
14. Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma.
15. Personal Metabolomics: A Global Challenge
16. Metabolomic Laboratory-Developed Tests: Current Status and Perspectives
17. Antigenic Essence: Upgrade of Cellular Cancer Vaccines
18. Mass spectrometry-based metabolomics diagnostics – myth or reality?
19. Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson’s Disease
20. In Situ Mass Spectrometry Diagnostics of Impaired Glucose Tolerance Using Label-Free Metabolomic Signature
21. Universal cancer vaccine: An update on the design of cancer vaccines generated from endothelial cells
22. Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro
23. Metabolomics Community in Russia: History of Development, Key Participants, and Results
24. Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
25. Diagnosis of Parkinson’s Disease by A Metabolomics-Based Laboratory-Developed Test (LDT)
26. Mass Spectrometry-Based Metabolomics Analysis of Obese Patients’ Blood Plasma
27. n-Butylamine for Improving the Efficiency of Untargeted Mass Spectrometry Analysis of Plasma Metabolite Composition
28. Metabolomic diagnostics and human digital image
29. Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations
30. Plasma Metabolome Signature in Patients with Early-stage Parkinson Disease
31. Label-free data standardization for clinical metabolomics
32. Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
33. Mass spectrometric signatures of the blood plasma metabolome for disease diagnostics
34. Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
35. Diagnosing Impaired Glucose Tolerance Using Direct Infusion Mass Spectrometry of Blood Plasma
36. Universal cancer vaccine
37. Mass spectrometric signatures of the blood plasma metabolome for disease diagnostics.
38. Proteomic Footprinting of Drug-Treated Cancer Cells as a Measure of Cellular Vaccine Efficacy for the Prevention of Cancer Recurrence
39. Proteolytically-cleaved Fragments of Cell Surface Proteins Stimulate a Cytotoxic Immune Response Against Tumoractivated Endothelial Cells In vitro
40. Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
41. Proteolytically-cleaved Fragments of Cell-surface Proteins from Live Tumor Cells Stimulate Anti-tumor Immune Response In vitro
42. Detection of the centriole tyr- or acet-tubulin changes in endothelial cells treated with thrombin using microscopic immunocytochemistry
43. Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson's Disease.
44. SANTAVACTM: Summary of Research and Development.
45. Evaluation of Dried Blood Spot Sampling for Clinical Metabolomics: Effects of Different Papers and Sample Storage Stability.
46. A Metabolomics Approach to Pharmacotherapy Personalization.
47. SANTAVAC TM : Summary of Research and Development.
48. SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.